Special Issue "Novel Viral Vector Systems for Gene Therapy"
QuicklinksA special issue of Viruses (ISSN 1999-4915).
Deadline for manuscript submissions: closed (30 December 2009)
Special Issue Editor
Guest Editor
Dr. Daniel Stone
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center in Seattle, Mailstop D3-100, 1100 Fairview Ave N, Seattle, WA 98109, USA
E-Mail:
Phone: +1 206 667 4875
Fax: +1 206 667 4411
Interests: development of novel viral vector systems for gene therapy; events that initiate innate immunity and toxicity following virus exposure; mechanisms that facilitate virus attachment, entry, replication and pathogenesis
Published Papers
Special Issue Information
Submission Information
All papers should be submitted to viruses@mdpi.com. To be published continuously until the deadline and papers will be listed together at the special issue website.
Submitted papers should not have been published nor be under consideration for publication elsewhere. All papers are refereed through a peer-review process. A guide for authors is available on the Instructions for Authors page. Viruses is a new international, peer-reviewed, quarterly open access journal published by MDPI.
Article Processing Charges (APC) for publication in this Open Access journal are waived for well-prepared manuscripts submitted by 30 June 2010. English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.
Keywords
- Foamy virus
- Adenovirus
- Adeno-associated virus
- Alpha virus
- Lentivirus
- Oncolytic viral vectors
- Cardiovascular gene therapy
- Musculoskeletal gene therapy
Last update: 14 December 2011